Stephen C. Glover - 18 May 2023 Form 3 Insider Report for Ambrx Biopharma Inc.

Role
Director
Signature
/s/ Sonja Nelson, Attorney-in-Fact for Stephen C. Glover
Issuer symbol
N/A
Transactions as of
18 May 2023
Net transactions value
$0
Form type
3
Filing time
19 May 2023, 16:05:12 UTC
Previous filing
13 Dec 2022
Next filing
18 Jul 2024

No securities are beneficially owned.

Remarks:

See Exhibit 24 for power of attorney.